3-IN-1 BLOOD PRESSURE PILL MORE EFFECTIVE THAN STANDARD CARE
THE WEEK India|October 06, 2024
A NEW 3-IN-1 blood pressure pill outperformed standard medication at lowering blood pressure in patients with uncontrolled hypertension.
3-IN-1 BLOOD PRESSURE PILL MORE EFFECTIVE THAN STANDARD CARE

It is estimated that over a billion people worldwide live with hypertension which is a leading risk factor for mortality, accounting for 10.8 million deaths a year.

The GMRx2 pill contains low doses of three blood pressure drugs—telmisartan, amlodipine and indapamide—and is taken once daily. The standard treatment for hypertension involves starting off with one medication, and if it’s not effective, adding on two or more drugs as needed.

Denne historien er fra October 06, 2024-utgaven av THE WEEK India.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra October 06, 2024-utgaven av THE WEEK India.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA THE WEEK INDIASe alt
Efficiency and innovation
THE WEEK India

Efficiency and innovation

As health care evolves, professionals must employ innovative methods to refine their skills

time-read
2 mins  |
December 01, 2024
Level up
THE WEEK India

Level up

Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres

time-read
2 mins  |
December 01, 2024
HOPE STEMS FROM A CELL
THE WEEK India

HOPE STEMS FROM A CELL

While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries

time-read
10+ mins  |
December 01, 2024
Mind matters
THE WEEK India

Mind matters

Your mindset can limit or expand your physical ability

time-read
3 mins  |
December 01, 2024
Cutting edge
THE WEEK India

Cutting edge

Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.

time-read
1 min  |
December 01, 2024
The smallest cut
THE WEEK India

The smallest cut

Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon

time-read
4 mins  |
December 01, 2024
Signalling a revolution
THE WEEK India

Signalling a revolution

Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin

time-read
7 mins  |
December 01, 2024
Wellness on demand
THE WEEK India

Wellness on demand

Starting as a doctor-patient chat platform, Medibuddy has evolved to be India's largest on-demand, full-stack digital health care platform

time-read
4 mins  |
December 01, 2024
HEARING AND VISION LOSS LINKED TO HEART DISEASE AND STROKE
THE WEEK India

HEARING AND VISION LOSS LINKED TO HEART DISEASE AND STROKE

A CHINESE STUDY PUBLISHED IN THE JOURNAL of the American Heart Association suggests that middle aged and older adults with sensory impairments, specifically hearing and vision loss, have an elevated risk of cardiovascular diseases, including stroke and heart attacks.

time-read
1 min  |
December 01, 2024
PETTICOAT CANCER AND THE SARI LINK
THE WEEK India

PETTICOAT CANCER AND THE SARI LINK

TYING YOUR UNDERSKIRT (petticoat) tightly around the waist when wearing a sari, can lead to \"petticoat cancer\" or \"sari cancer,\" as it was previously called. Tying the underskirt too tightly can cause constant cord friction that can lead to chronic inflammation, skin ulceration and, in rare cases, skin cancer.

time-read
1 min  |
December 01, 2024